Q32 Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.24

+0.37 (+9.56%)

As of Feb 8, 2:18 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +559.0% upside

Low Target $24.18

Average Target $27.94

High Target $39.76

Current Price $4.24

Current
$4.24

Target
$27.94

$24.18 $27.94 avg $39.76

Scenario Analysis

Bear Case

$24.18

470.3%

Low target

Base Case

$27.94

+559.0%

Avg target

Bull Case

$39.76

+837.7%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$31.26

-86.4% from high

52-Week Low

$20.39

+-79.2% from low

Target vs 52W High

$27.94

-10.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%